Mendus presents comprehensive ADVANCE II immunomonitoring data at the EHA Annual Meeting 2023
VIDIDENCEL ADMINISTRATION LED TO BROAD IMMUNE ACTIVATION WITH INNATE AND ADAPTIVE IMMUNE RESPONSES OBSERVED Mendus…
Month: June 2023
Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
PRESS RELEASE Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation…
Oxurion Finalizes Enrollment in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema
Top-line Data Expected in Q4 2023 Leuven, BELGIUM, Boston, MA, US – June 12, 2023…
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland
LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) — SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered…
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
Novartis to acquire Chinook for $40 per share in cash, with potential to receive up…
Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics for USD 3.2bn upfront (USD 40 / share)
Ad hoc announcement pursuant to Art. 53 LR Chinook Therapeutics is a clinical-stage biopharmaceutical company…
Ipsen to present new data on clinical outcomes and patient validation tools from growing rare liver disease portfolio at EASL 2023
Seven abstracts to be presented demonstrating treatment effects of Bylvay® in two cholestatic liver diseases,…
Idorsia launches QUVIVIQ (daridorexant) in Switzerland – a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning
QUVIVIQ™ is indicated for the treatment of adult patients with insomnia, characterized by symptoms present…
ERYTECH Responds to Akkadian’s Disinformation
ERYTECH Responds to Akkadian’s Disinformation Akkadian’s challenge of the merger is based on incomplete…
VSFG Proudly Sponsors the “DOUBLE DUCKS” Project and Partners with DOTTED on the Official Digital Collectible Collection to Drive Web3 Mass Adoption
HONG KONG, Jun 12, 2023 – (ACN Newswire) – Venture Smart Financial Holdings Limited (“VSFG”),…
SNS Network Technology’s JOI for All Initiative Assisting Education Transformation
IPOH, Malaysia, Jun 12, 2023 – (ACN Newswire) – SNS Network Technology Berhad, an ICT…
Antin Infrastructure Partners Announces a Voluntary Cash Tender Offer for 100% of Opdenergy
Cash tender offer at €5.85 per share with intention to delist Opdenergy shares The price…
Vivid Fire Kitchen Heats Up Vivid Sydney 2023 With A Sizzling Local Line-Up
SINGAPORE June 12, 2023 – (ACN Newswire) – The Vivid Food program presents a stellar…
Dynasty Launches New NIANHUA Series in 2023 to Meet Needs of Different Consumer Groups
HONG KONG, Jun 12, 2023 – (ACN Newswire) – Dynasty Fine Wines Group Limited (“Dynasty”…
TapestryX Protocol Rated by the Government Blockchain Association (GBA)
Washington, D.C., Jun 12, 2023 – (ACN Newswire) – TapestryX (https://tapestryx.com), a layer one blockchain…
Andreessen Horowitz (“a16z”) Announces its First International Expansion to the United Kingdom
The company’s crypto practice, which manages $7.6 billion (£6.05 billion) of committed capital, will establish…
Tech Alert: BrainChip Examines New Approach to Optimizing Time-series Data
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–A new white paper by BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF,…
Intellia Therapeutics Announces New Positive Clinical Data from Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema (HAE)
Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for…
Kura Oncology Presents Late-Breaking Clinical Data for Menin Inhibitor Ziftomenib at 2023 European Hematology Association (EHA) Congress
– 35% CR rate (7/20) among patients with relapsed/refractory NPM1-mutant AML treated at 600 mg…
Reyna Law Firm Enters American Academy of Attorneys’ 500 Million Dollar Club
Reyna Law Firm announced its recent induction in the American Academy of Attorneys’ 500 Million…